Nuclear Lncrna Knockdown
Nuclear Lncrna Knockdown - Related Videos
06:13
Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells
0 Views •
2026
This experimental protocol provides a stable, cost-effective, and efficient method that combines lncRNA knockdown with colony-forming assays to quantify the effect of lncRNA on osteosarcoma cell proliferation.
02:39
lncRNA - Long Non-coding RNAs
0 Views •
2020
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
13:54
Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
0 Views •
Cited by 3 •
2012
Contribution of the ACF chromatin remodeling factor to E4orf4-induced cell death was measured. The protocol includes selection of cell clones in which doxycycline treatment induces conditional knockdown of the ACF subunits Acf1 and SNF2h, and use of the DAPI assay to measure E4orf4-induced cell death in the inducible cell lines.
04:36
Production of Synthetic Nuclear Melt Glass
0 Views •
Cited by 1 •
2016
A protocol for the production of synthetic nuclear melt glass, similar to trinitite, is presented.
03:18
Nuclear Stability
0 Views •
2020
Protons and neutrons, collectively called nucleons, are packed together tightly in a nucleus. With a radius of about 10−15 meters, a nucleus is quite small compared to the radius of the entire atom, which is about 10−10 meters. Nuclei are extremely dense compared to bulk matter, averaging 1.8 × 1014 grams per cubic centimeter. If the earth’s density were equal to the average nuclear density, the earth’s radius would be only about 200 meters. To hold positively charged protons together in the...
FAQs
Complementary antisense oligonucleotides bind the targeted nuclear lncRNA and create an RNA-DNA hybrid. RNase H recognizes this hybrid and cleaves the RNA strand, promoting transcript degradation. Because the strategy acts on the RNA molecule rather than changing genomic DNA, researchers can examine the consequences of reducing the transcript while leaving the underlying genome unaltered.
A nuclear lncRNA may influence gene regulation through transcriptional activity or association with chromatin-related complexes. Reducing such a transcript therefore allows researchers to test whether those nuclear functions contribute to cancer-cell behavior. The most informative interpretation connects the knockdown with changes in transcription or chromatin-associated complexes, rather than considering only the amount of RNA removed.
The direction and pattern of downstream changes provide the key evidence. Effects on proliferation, apoptosis, invasion, or treatment response can indicate whether the lncRNA supports tumor development or instead suppresses it. A proposed mechanism becomes more persuasive when transcript reduction is accompanied by changes in the gene-regulatory or cancer-related outcomes being investigated.
Researchers first deliver complementary antisense oligonucleotides to cells containing the nuclear lncRNA of interest. They then assess consequences of transcript reduction, including transcription, chromatin-associated complexes, proliferation, apoptosis, invasion, or treatment response. This workflow links the molecular perturbation to cellular or regulatory outcomes and helps determine whether the lncRNA has a functional role in cancer biology.
Measurements can span molecular, regulatory, and cellular levels. Transcriptional changes and alterations in chromatin-associated complexes address how the lncRNA may regulate nuclear processes, while proliferation, apoptosis, and invasion reveal effects on cancer-cell behavior. Treatment-response measurements add a therapeutic dimension by showing whether transcript reduction changes how cells respond to treatment.
Nuclear lncRNA knockdown provides a functional test of whether reducing a candidate transcript changes cancer-relevant phenotypes. Researchers can compare the resulting effects on tumor-associated cell behavior and treatment response with the proposed role of the lncRNA. Consistent changes can help validate the transcript as a therapeutic target and clarify its regulatory mechanism in cancer cells.